SPECTRILA Trademark

Trademark Overview

On Thursday, September 1, 2011, a trademark application was filed for SPECTRILA with the United States Patent and Trademark Office. The USPTO has given the SPECTRILA trademark a serial number of 79103570. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 2, 2021. This trademark is owned by medac Gesellschaft für klinische Spezialpräparate mbH. The SPECTRILA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating cancer and auto-immune diseases; Medicines for treating cancer and auto-immune diseases; Chemical preparations for medical purposes, namely, chemical reagents for diagnostic purposes; Medical plasters; Surgical dressings; All purpose disinfectants
spectrila

General Information

Serial Number79103570
Word MarkSPECTRILA
Filing DateThursday, September 1, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 2, 2021
Registration Number4192526
Registration DateTuesday, August 21, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating cancer and auto-immune diseases; Medicines for treating cancer and auto-immune diseases; Chemical preparations for medical purposes, namely, chemical reagents for diagnostic purposes; Medical plasters; Surgical dressings; All purpose disinfectants
Translation of Words in MarkThe word(s) "SPECTRILA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
Address22880 Wedel
Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Address22880 Wedel
Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Address22880 Wedel

Trademark Events

Event DateEvent Description
Sunday, March 20, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 20, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, January 10, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 16, 2019GENERIC MADRID TRANSACTION SENT TO IB
Monday, December 16, 2019GENERIC MADRID TRANSACTION CREATED
Friday, November 22, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 22, 2019CANCELLED SECTION 71
Monday, August 21, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, February 16, 2017NEW REPRESENTATIVE AT IB RECEIVED
Sunday, December 23, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 10, 2012NOTIFICATION PROCESSED BY IB
Tuesday, December 4, 2012FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 4, 2012FINAL DISPOSITION PROCESSED
Wednesday, November 21, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 21, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, June 5, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 16, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 16, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 27, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 27, 2012EXAMINER'S AMENDMENT ENTERED
Friday, April 27, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 27, 2012EXAMINERS AMENDMENT E-MAILED
Friday, April 27, 2012EXAMINERS AMENDMENT -WRITTEN
Thursday, April 26, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 26, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 19, 2012ASSIGNED TO LIE
Wednesday, April 11, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 11, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2012REFUSAL PROCESSED BY IB
Friday, December 16, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 16, 2011REFUSAL PROCESSED BY MPU
Friday, December 16, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 15, 2011NON-FINAL ACTION WRITTEN
Thursday, December 15, 2011ASSIGNED TO EXAMINER
Tuesday, November 1, 2011APPLICATION FILING RECEIPT MAILED
Friday, October 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 27, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

spectrila diseases chemical purposes immune medical treating auto cancer preparations surgical